In this study, 334/399 (83.7%) cases of NSCLC were demonstrated to have elevated expression of EGFR protein (≥2+) by using monoclonal antibody, the rate much higher than standard detection at genetic level (40.6%). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.